PuSH - Publication Server of Helmholtz Zentrum München

Lonardo, A.* ; Stefan, N. ; Mantovani, A.*

Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer.

Trends Endocrinol. Metab. 36, 610-613 (2025)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Liver fibrosis and biological sex variably modulate the risks of hepatocellular carcinoma (HCC) and extrahepatic cancers (EHCs) arising in the context of metabolic dysfunction-associated steatotic liver disease (MASLD). Here, we highlight how these variables may have implications in the setting of chemoprevention and precision medicine approaches in MASLD and guide additional research.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Comment, Opinion
ISSN (print) / ISBN 1043-2760
e-ISSN 1879-3061
Journal Trends in Endocrinology and Metabolism
Quellenangaben Volume: 36, Issue: 7, Pages: 610-613 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Reviewing status Peer reviewed
Institute(s) Institute of Diabetes Research and Metabolic Diseases (IDM)